February 11, 2011 — In patients with severe spasticity related to multiple sclerosis (MS), intrathecal baclofen (ITB) using a programmable, subcutaneously implanted pump can be an effective ...

Spasticity may be a term that’s new to you, but it’s a condition that affects more than 12 million people around the world. [8] It’s a complicated condition, but simply put, it’s extreme muscle ...

St. Paul-based CNS Therapeutics announced on Tuesday that the FDA approved its drug to treat severe spasticity. The drug, called Gablofen, is administered through a drug pump and is the generic ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...

Scientists from Far Eastern Federal University (FEFU) together with leading international experts suggest reconsidering the existing treatment protocol for severe spasticity, one of the main ...

Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes. PHILADELPHIA — Real ...

BRISBANE, Calif.--(BUSINESS WIRE)--Delpor, Inc. (Delpor), a clinical stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic conditions, ...

Cerebral Palsy has been linked to a condition called cryptorchidism in males - when one or both of the testicles are not present in the scrotum. A new study in Developmental Medicine & Child Neurology ...

GABLOFEN (baclofen) prefilled syringes by Mallinckrodt Mallinckrodt announced that the FDA has approved Gablofen (baclofen injection) prefilled syringes. A refill convenience kit has been re-designed ...

DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal drug ...